Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Aina, Adeyinka Temitope (2012)
Languages: English
Types: Unknown
Using confocal Raman spectroscopy/microscopy, we have monitored pharmaceutical crystallisation 'in situ' in three model (well characterised polymorphic systems) Active Pharmaceutical Ingredients (APIs) and one previously unstudied system where polymorphism had not being reported prior to this study: flufenamic acid, a Non Steroidal Non-Inflammatory Drug (NSAID); nifedipine, an antihypertensive; tolbutamide, used in the treatment of type II diabetes; and imipramine hydrochloride, an antidepressant respectively. Constrained crystallisation from the solid amorphous state was utilised to kinetically trap polymorphs via the Ostwald's rule of stages. Particular emphasis was placed on the phonon-mode/low wavenumber region (4-400cm-1) of the Raman spectral window (this region provides useful information about lattice environment). In all cases our results from the Raman experiments were complemented with similar experiments using Differential Scanning Calorimetry (DSC) and Variable Temperature X-ray Powder Diffraction (VTXRPD). To reduce data complexity, principal component analysis was deployed and found to be extremely effective. In chapter two, a multi-technique study of flufenamic acid (FFA) was carried out which served as a groundwork for later chapters. A solid-solid transformation between two forms of FFA (forms I and III) was observed, due to the abrupt nature of this transition, the 'Lindemann vibrational catastrophe' was envisaged as a possible mechanism for the transformation. Using FFA as a test case in chapter three, polymorphic transformations was monitored in both FFA forms I and III using in situ Raman spectroscopy (as well as VTXRPD) by adopting the constrained crystallisation approach. The approach showed excellent promise (with the XRPD patterns of FFA form II and one unknown form uncovered) and was further explored in later chapters using a variety of pharmaceutical materials. While in chapter four, the interconversion between the different polymorphs of nifedipine was studied using the constrained crystallisation approach monitored using in situ Raman spectroscopy (together with VTXRPD and DSC), our results compared favourably well with those previously published in literature. We also reported for the first time the phonon-mode Raman spectral for this system as earlier publications focussed only on the 'traditional' fingerprint region. Similarly in chapter five, in situ Raman spectroscopy was also used to monitor the polymorphic transformations in tolbutamide (using the constrained crystallisation approach), results from the Raman analysis was compared with those obtained from VTXRPD and found to be in agreement. Thus further showing that Raman spectroscopy combined with the constrained crystallisation approach is a veritable tool for monitoring polymorphic transitions. In chapter six, preliminary results (Raman/XRPD/DSC) showed for the first time that imipramine hydrochloride exhibits polymorphism, with the possibility of at least two new polymorphs. Combination of state of the art spectroscopic techniques with appropriate statistical methods, X-ray powder diffraction and DSC was shown to be an extremely effective approach to investigating and characterising polymorphism in drugs, often using only milligram or sub-milligram sample quantities. Lastly in chapter seven, the novel technique of Transmission Raman Spectroscopy (TRS) was employed in carrying out a quantitative study of polymorphic content in a model pharmaceutical formulation and the results obtained compared with those from traditional backscattering geometry. The transmission method is shown to provide a true bulk measurement of the composition, being unaffected by systematic or stochastic sub-sampling issues that can plague traditional backscattering geometries.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Jarkko Pirttimäki, E. Laine, J. Ketolainen, and P. Paronen, Efffects of grinding and compression on crystal structure of anhydrous caffeine, Int. J. Pharm.(1993), 95, 93-99
    • 2. Sarah Al-Dulami, Adeyinka Aina and Jonathan Burley, Rapid polymorph screening on milligram quantities of pharmaceutical material using phonon-mode Raman spectroscopy, CrystEngComm, (2010), 12, 1038-1040
    • 3. Jain, P., Banga, A.K., Inhibition of crystallization in drug-in-adhesive-type transdermal patches. Int. J. Pharm.(2010), doi:10.1016/j.ijpharm.2010.04.042
    • 4. Preface, Pharmaceutical solid polymorphism in drug development and regulation; Advanced Drug delivery Reviews, (2004), 56, 235-236
    • 5. Eun Hee Lee, Stephan X.M. Boerrigter, Alfred C.F. Rumondor, Sai P. Chamathy and Stephen Byrn, Formation and solid-state characterization of a salt-induced metastable polymorph of Flufenamic Acid, Crystal Growth and Design, (2008), Vol 8, No 1, 91-97
    • 6. Polymorphism in the Pharmaceutical Industry, Edited by R. Hilfiker 2006 WILEY-VCH verlag GmbH & Co KgaA, Weinheim, ISBN 3-527-31146-7
    • 7. Threlfall, T.L., Analysis of organic polymorphs. A review. Analyst, (1995), 120 , 2435-2460
    • 8. Grant, D.W.J., Theory and origin of polymorphism in polymorphism in pharmaceutical Solids, H.G. Brittain, Editor. 1999, Marcel Dekker, Inc., New York. 1-33
    • 9. Di Martino, P., Guyot-Hermann, A.M., Conflant, P., Drache, M., and Guyot, J.C., A new pure paracetamol for direct compression: The orthorhombic form. International Journal of Pharmaceutics, (1996), 128, 1-8
    • 10. Norbert Rasenack, B. W. Müller, Crystal habit and tableting behaviour, Int. J. Pharm.(2002), 224, 45-57
    • 11. Sun, C. and Grant, D.J.W., Influence of crystal structure on the tableting properties of sulfamerazine polymorphs, Pharmaceutical Research, (2001), 18, 274-280
    • 12. Suihko, E., Lehto, V.-P., Ketolainen, J., Laine and Paronen, P., Dynamic Solid-State and tableting properties of four theophylline forms, International Journal of Pharmaceutics, (2001), 158, 225-236
    • 13. Kahela, P., Aaltonen, R., Lewing, E., Anttila, M., and Kristofferson, E., Pharmacokinetics and dissolution of two crystalline forms of carbamazepine, International Journal of Pharmaceutics, (1983), 14, 103-112
    • 14. Meyer, M.C., Straughn, A.B., Jarvi, E.J., Wood, G.C., Pelsor, F.R. and Shah, V.P., The bioinequivalence of carbamazepine tablets with a history of clinical failures, Pharmaceutical Research, (1992), 9, 1612-1616
    • 15. Chemburkar, S.R., Bauer, J., Deming, K., Spiwek, H., Patel, K., Morris, J., Henry, R., Spanton, S., Dziki, W., Porter, W., Quick, J., Bauer, P., Donaubauer, J., Narayanan, B.A., Soldani, M., Riley, D., and McFarland, K, Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development, Organic Process Reasearch & Development, (2000), 4, 413-417
    • 16. Cushla M. McGoverin, L. C. H. Ho, J. A. Zeitler, C. J. Strachan, K. C. Gordon and Thomas Rades, Quantification of binary polymorphic mixtures of ranitidine hydrochloride using NIR spectroscopy, Vibrational Spectroscopy, (2006), 41, 225-231
    • 17. Norman Chieng, S. Rehder, D. Saville, T., T. Rades and J. Aaltonen, Quantitative solid-state analysis of three forms of ranitidine hydrochloride in ternary mixtures using Raman spectrscopy and X-ray powder diffraction, Journal of Pharmaceutical and Biomedical Research, (2009), 49, 18-25
    • 18. Singhal D., W. Curatolo, Drug polymorphism and dosage form design: a practical perspective, Adv. Drug Del. Rev., (2004), 56, 335-347
    • 19. Dr. Jan-OlavHenck, Diversity amidst Similarity: A multidisciplinary approach to polymorhs, solvates & phase relations, Bayer HealthCare, Erice, June 2004
    • 20. Artur Burger and R. Ramberger, On the polymorphism of pharmaceuticals and other molecular crystals. I. Theory of thermodynamic rules, Mikrochim. Acta 11 (1979), 259-271
    • 21. Ostwald, W. Z. Studien ueber die Bildung und Umwandlung fester Koerper, Phys. Chem. (1897), 22, 289
    • 22. Terry Threlfall, Structural and thermodynamic explanation of Oswald's Rule, Organic Process Research & Development, (2003), 7, 1017-1027
    • 23. 6th International conference on pharmacy and applied physical chemistry, Ascona, Switzerland, May 26-30, 2002
    • 24. Beckmann W., Otto W., Budde U. Crystallisation of the stable polymorph of hydroxytriendione: Seeding process and effects of purity. Organic Process Reasearch & Development, (2001), 5, 387-392
    • 25. Shachtshneider T. P., Boldryrev V. V., Phase transformations in sulfathiazole during mechanical activation, Drug Dev. Ind. Pharm., (1993), 19, 2055-2067
    • 26. Otsuka M., Otsuka K., Nobuyoshi K., Relation between polymorphic transformation pathway during grinding and the physicochemical properties of bulk powders for pharmaceutical preparations, Drug Dev. Ind. Pharm., (1994), 20, 1649-1660
    • 27. Aaltonen J.,Koradia V., Gordon K.C., Solid form screening-a review, Eur. J. Biopharm. (2009) Jan;71(1):23-37. Epub 2008 Jul 31
    • 28. Bhadeshia H. K. D. H., Lecture notes, University of Cambridge, Material Science and Metallurgy 2002
    • 29. Christopher Hammond, The basics of crystallography and diffraction (second edition), Oxford University Press, Oxford UK, 2001
    • 30. Barbara L. Dutrow, Christine M. Clark, Geochemical instrumentation and analysis, X-ray Powder Diffraction, Geochemsheets Carleton University U.S.A 2008
    • 31. David E. Bugay, Solid-state nuclear magnetic resonance spectroscopy: Theory and pharmaceutical application, Pharmaceutical Research, (1993), 10, 317-327
    • 32. Andrew E. R., The narrowing of NMR spectra of solids by high-speed specimen rotation and the resolution of chemical shift and spin-multiplet structures for solids, Prog. NMR Spectroscopy (1971), 8, 1-39
    • 33. Andrew E. R., A. Bradbury and R. G. Eades, Removal of dipolar broadening of nuclear magnetic resonance spectra of solids by specimen rotation, Nature, (1959), 183, 1802-1803 35. Pavel Matousek and A. W. Parker, Non-invasive probing of pharmaceutical capsules using transmission Raman spectroscopy, J. Raman Spectrosc., (2007), 38, 563-567
    • 37. Eliasson C., N. A. Macleod and P. Matousek, Non-invasive detection of powders concealed within diffusely scattering plastic containers, Vibrational Spectroscopy, (2008),Vol. 48, Issue 1, 8-11
    • 38. Adeyinka Aina, Michael D. Hargreaves, Pavel Matousek and Jonathan C. Burley, Transmission Raman spectroscopy as a tool for quantifying polymorphic content of pharmaceutical formulations, Analyst, (2010), 135, 2328 - 2333, DOI: 10.1039/c0an00352b
    • 39. Nicholas Stone, P. Matousek, Advanced Transmission Raman Spectroscopy: A Promising Tool for Breast Disease Diagnosis Cancer Res, (2008), 68, 4424-4430
    • 40. McCrone W. C., Fusion methods in chemical microscopy, Interscience Publishers, Inc., New York, 1957
    • 41. Maria, Kuhnert-Brandstätter, Thermomicroscopy in the analysis of pharmaceuticals, Pergamon Press, Oxford, 1971
    • 42. David J. Berry, Colin C. Seaton, William Clegg, Ross W. Harrington, Simon J. Coles, Peter N. Norton, Michael B. Hursthouse, Richard Storey, William Jones, Tomislav Friščič, and Nicholas Blagden, Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients, Crystal Growth and Design, (2008), Vol. 8, No 5, 1697-1712
    • 43. Imre M. Vitez1, Ann W. Newman, Martha Davidovich, Chris Kiesnowski, The evolution of hot-stage microscopy to aid solid-state characterizations of pharmaceutical solids, Thermochimica Acta, (1998), 324, 187-196
    • 44. Mura P., M.T. Faucci, A. Manderioli, G. Bramanti, L. Ceccarelli, Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy, Journal of Pharmaceutical and Biomedical Analysis, (1998), 18, 151-163
    • 45. Bartolomei M., P. Bertocchi, M. Cotta Ramusino, E. Ciranni Signoretti, Thermal studies on the polymorphic modifications of (R,S) propranolol hydrochloride, Thermochimica Acta, (1998), 321, 43-52
    • 46. Haitao Li 1, Y.-H. Kiang, Janan Jona, Multiple approaches to pharmaceutical polymorphism investigation-A case study, European Journal of Pharmaceutical Sciences, (2009), 38, 426- 432
    • 47. Lian Yu, Susan M. Reutzel and Gregory A. Stephenson, Physical characterization of polymorphic drugs: an integrated characterization strategy, Reviews, Research Focus, PSTT Vol. 1, No. 3 June 1998, 118-127
    • 48. W. J. Krzanowski, Principles of multivariate analysis, a user's perspective, revised edition, Oxford University press, (2000)
    • 50. Derya Kara, Evaluation of trace metal concentrations in some herbs and herbal teas using principal component analysis, Food Chemistry, (2009), 114, 347-354
    • 51. Patricia Henson and Steve Lowry, Analysing Polymorphs with Raman spectroscopy, Drug Discovery & Development, Webcast series, January 2006
    • 52. Wolfgang Beckmann, Seeding the desired polymorph: Background, possibilities, limitations and case studies, Organic Process Research & Development, 4, (2000), 372-383
    • 53. Li T., Kenneth R. Morris, Kinam Park, Influence of Tailor-made additives on etching patterns of acetaminophen single crystals, Pharm. Res., 18, (2001), 398-402
    • 54. Weissbuch I., L. Leiserowitz, M. Lahav, Crystal morphology control with tailor-made additives; A stereochemical control: In Advances in Crystal Growth Research (Sato K., ed.), 381-400, Elvesier
    • 55. Rubin-Preminger, J.M. and Bernstein, J., 3-Aminobenzenesulfonic acid: a disappearing polymorph. Cryst. Growth Des., 5, (2005), 1343-1349
    • 56. Kwon O.P., M. Jazbinzek, A. Choubey, P. A. Losio, V. Gramlich and P. Günter, Morphology and polymorphism control of organic polyene crystals by tailor-made auxiliaries, Cryst. Growth Des., 6, (2006), 2327-2332
    • 57. Kellogg, R.M., Kaptein B., Vries T.R., Dutch resolution of racemates and the roles of solid solution formation and nucleation inhibition, Top. Curr. Chem. 269, (2007), 159-197 (Novel Optical Resolution Technologies)
    • 58. Mitchell C.A., Yu L., Ward M. D., Selective nucleation and discovery of organic polymorphs through epitaxy with single crystal substrates. J. Am. Chem. Soc., 123, (2001), 10830-10839
    • 59. Blagden, N., Crystal engineering of polymorph appearance: the case of sulphathiazole, Powder Technol. 121, (2001), 46-52
    • 60. Rafilovich, M. and Bernstein, J., Serendipity and four polymorphic structures of benzidine C12H12N2, J. Am. Chem. Soc. 128, (2006), 12185-12191
    • 61. Day, G.M., J.A. Zeitler, W. Jones, T.Rades , Investigating the latent polymorphism of maleic acid, (2006), Chem. Commun. 54-56
    • 62. Fages, J., Hubert Lochard, Jean-Jacques Letourneau, Martial Sauceau and Elisabeth Rodier, Particle generation for pharmaceutical applications using supercritical fluid technology. Powder Technol., 141, (2004), 219-226
    • 63. Krukonis,V. (1984) Supercritical fluid nucleation of difficult-to-comminute solids. In Proceedings of the Annual Meeting AIChE, paper 140 f, T-214
    • 64. Kordikowski, A., T. Shekunov, P. York, Polymorph control of sulfathiazole in supercritical CO2, Pharm. Res., 18, (2001), 682-688
    • 65. Hooton, J.C., Caroline S. German, Martyn C. Davies, Clive J. Roberts A comparison of morphology and surface energy characteristics of sulfathiazole polymorphs based upon single particle studies, Eur. J. Pharm. Sci., 28, (2006), 315-324
    • 66. Garetz, B.A., Aber J. E., Goddard N. L., Young R. G., Myerson A. S., Non-photochemical, polarization-dependent, laser induced nucleation in supersaturated aqueous urea solutions. Phys. Rev. Lett. 77, (1996), 3475-3476
    • 67. Sun, X., Bruce A. Garetz, Allan S. Myerson, Supersaturation and polarization dependence of polymorph control in the non-photochemical laser-induced nucleation (NPLIN) of aqueous glycine solutions, Cryst. Growth Des. 6, (2006), 684-689
    • 68. Blundell, T. L., Jhoti H., Abell C., High-throughput crystallisation for lead discovery in drug design, Nat. Rev. Drug Discov. 1, (2002), 45-54
    • 69. Peterson, M.L., Morissette S.L., McNulty C., Coldsweig A., Shaw P., LeQuesne M., Monagle J., Encina N., Marchionna J., Johnson A., Gonzalez-Zugasti J., Lemmo A.V., Ellis S.J., Cima M.J., Almarsson O., Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III, J. Am. Chem. Soc., 124, (2002), 10958-10959
    • 70. Stewart, L. Clark R. and Behnke C., High-throughput crystallisation and structure determination in drug discovery, Drug Discov. Today 7, (2002), 187-196
    • 71. Storey, R. A., R. Docherty and P. D. Higginson, Integration of high throughput screening methodologies and manual processes for solid form selection, Am. Pharm. Rev., 6, (2003), 100-105
    • 72. Sherry L. Morissette, Orn Almarsson, Matthew L. Peterson, Julius F. Remenar, Michael J. Read, Anthony V. Lemmo, Steve Ellis, Michael J. Cima, Colin R. Gardner, High-throughput crystallisation: polymorphs, salts, co-crystals and solvates of pharmaceutical solids, Adv. Drug. Deliv. Rev., 56, (2004), 275-300
    • 73. Rupp, B., Automated high throughput drug target crystallography, Am. Pharm. Rev., (2005), 127-131
    • 74. Chayen, N. E., Optimisation techniques for automation and high throughput, Methods in Molecular Biology, Vol. 363, (2007), 175-190
    • 75. Sudha R. Vippagunta, Harry G. Brittain, D. J. W. Grant, Crystalline solids, Adv. Drug Delivery Rev., 48(1), 3, (2001), 3-26
    • 76. Chan F. C., J. Anwar, R. Cernik and R. M. Wilson, Ab initio structure determination of sulfathiazole polymorph V from synchrotron X-ray powder diffraction data, J. Appl. Cryst., 32, (1999), 436-441
    • 77. Caroline McGregor and Emma Bines, The use of high-speed differential scanning calorimetry (Hyper-DSC™) in the study of pharmaceutical polymorphs, International Journal of Pharmaceutics, Vol. 350, Issues 1-2, (2008), 48-52
    • 78. Graeme M. Day, J. A. Zeitler,W. Jones, T. Rades, and P. F. Taday,Understanding the Influence of Polymorphism on Phonon Spectra: Lattice Dynamics Calculations and Terahertz Spectroscopy of Carbamazepine, J. Phys. Chem. B, 110(1), (2006), 447-456
    • 79. Nicholas Stone, P. Matousek, Advanced Transmission Raman Spectroscopy: A Promising Tool for Breast Disease Diagnosis Cancer Res, (2008), 68, 4424-4430
    • 80. Krc J., Jr., Crystallographic properties of flufenamic acid, Microscope, (1977), 25 31-45
    • 81. Xiaoming Chen, Joseph G. Stowell, Kenneth R. Morris and Stephen R. Byrn, Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction, Journal of Pharmaceutical and Biomedical Analysis,(2010), 51, 866-874
    • 83. Zdzislaw Galdecki, Marek Leszek Glowka and Zbigniew Gorkiewicz, Examination of the polymorphism of 2-[(3-Trifluoromethyl)Phenyl]Aminobenzoic acid, Acta. Polon. Pharm. XXXV, No.1, (1978), 77-79
    • 84. Gilpin R. K.,and W. Zhou, Infrared Studies of the Polymorphic states of the fenamates, Journal of Pharmaceutical and Biomedical Analysis, (2005), 37, 509-515
    • 85. Artur Burger and Rudolf Ramberger, Thermodynamishe Beziehungen Zwischen Polymorphen Modifikationen: Flufenaminsaure and Mefenaminsaure, Mikrochimita Acta. Wien, I, (1980), 17-28
    • 86. German L. Perlovich, Artem O. Surov and Annette Bauer-Brandl, Thermodynamic properties of Flufenamic and Niflumic acids- Specific and non-specific interactions in solution and in cystal lattices, mechanism of solvation, partitioning and distribution, Journal of Pharmaceutical and Biomedical Analysis, (2007), 45, 679-687
    • 87. Krishna Murthy H. M., T. N. Bhat and M. Vijayan, Structure of a new crystal form of 2- {[3- (Trifluoromethyl)phenyl]amino}benzoic acid, Acta Cryst. B38, (1982), 315-317
    • 88. Juan Jose Lozano, Ramon Pouplana, Manuel Lopez and Juan Ruiz, Conformational analysis of the antiinflammatory fenmates: A molecular mechanics and semiempirical molecular orbital study, Journal of Molecular Structure (Theochem), (1995), 335, 215-227
    • 89. Facchin G., M. H. Torre, E. Kremer, O. E. Piro and E. J. Baran, Crystal structure and spectrocopic behaviour of a binuclear Copper(II) complex of Flufenamic Acid and Dimethlformamide, Z. Anorg. Allg. Chem., (1998), 264, 2025-2028
    • 90. Yuerong Hu, Hakan Wikstrom, Stephen R. Byrn, Lynne S. Taylor, Estimation of the transition temperature for an enantiotropic polymorphic sytem from the transformation kinetics monitored using Raman spectroscopy, Journal of Pharmaceutical and Biomedical Analysis, (2007), 45, 546-551
    • 92. Romero S., P. Bustamante, B. Escalera, M. Cirri, P. Mura, Characterization of the solid phases of paracetamol and fenamates at equilibrium in saturated solutions, J. Therm. Anal. Calorim., (2004), 77, 541-554
    • 93. Jenkins R., R.W. Gould, D. Gedcke, Quantitative X-ray Spectrometry, second ed., Marcel Dekker, New York, 1995
    • 94. Alexander L., H.P. Klug, Basic aspects of X-ray absorption in quantitative diffraction analysis of powder mixtures, Anal. Chem., (1948), 20, 886-889
    • 95. Hassan Refat H. Ali, Howell G.M. Edwards, Michael D. Hargreaves, Tasnim Munshi, Ian J. Scowen, Richard J. Telford, Vibrational spectroscopic characterization of salmeterol xinofoate polymorphs and a preliminary investigation of their transformation using simultaneous in situ portable Raman spectroscopy and differential scanning calorimetry, Analytica Chimica Acta, (2008), 620, 103-112
    • 97. Aldo Brillante, Ivano Bilotti, Fabio Biscarini, Raffaele Guido Della Valle, Elisabetta Venuti, Polymorphs of α-sexithiophene probed by lattice phonon Raman microscopy, Chemical Physics, (2006), 238, 125-131
    • 98. Gamberini M. C., C. Baraldi, A. Tinti, F. Palazzoli, V. Ferioli, Vibrational study of tamoxifen citrate polymorphism, Journal of Molecular Structure, (2007), 840, 29-37
    • 99. Tomasz Zych, Tomasz Misiaszek, M. Magdalena Szostak, Polymorphism of 2-nitroaniline studied by calorimetric (DSC), structural (X-ray diffraction) and spectroscopic (FT-IR, Raman, UV-Vis) methods, Chemical Physics, (2007), 340, 260-272
    • 100. Yu. A. Chesalov, V.P. Baltakhinov, T.N. Drebushchak, E. V. Boldyreva, N.V. Chukanov, V.A. Drebushchak, FT-IR and FT-Raman spectra of five polymorphs of chlorpropamide. Experimental study and ab initio calculations, Journal of Molecular Structure, (2008), 891 75-86
    • 101. Martin E. Auer, Ulrich J. Griesser and Juergen Sawatzki, Oualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy, Journal of Molecular Structure, (2003), 661-662, 301-317
    • 102. Goryainov S. V., E.V. Boldyreva, E.N. Kolesnik, Raman observation of a new (ζ) polymorph of glycine?, Chemical Physics Letters, (2006), 419, 496-500
    • 103. Gamberini M. C., C. Baraldi, A. Tinti, C. Rustichelli, V. Ferioli, G. Gamberini, Solid state characterization of chloramphenicol palmitate. Raman spectroscopy applied to pharmaceutical polymorphs, Journal of Molecular Structure, (2006), 785, 216-224
    • 104. Babkov L., J. Baran, N.A. Davydova, V.I. Mel'nik, K.E. Uspenskiy, Raman spectra of metastable phase of benzophenone, Journal of Molecular Structure, (2006), 792-793, 73-77
    • 105. Baraldi C., M.C. Gamberini, A. Tinti, F. Palazzoli, V. Ferioli, Vibrational study of acetazolamide polymorphism, Journal of Molecular Structure, (2009), 918, 88-96
    • 106. Zoltan Nemet, Adam Demeter, Gyorgy Pokol, Quantifying low levels of polymorphic impurity in clopidogrel bisulphate by vibrational spectroscopy and chemometrics, Journal of Pharmaceutical and Biomedical Analysis, (2009), 49, 32-41
    • 107. Silvia L. Cuffini, Javier F. Ellena, Yvonne P. Mascarenhas, Alejandro P. Ayala, Heinz W. Sielser, Josue Mendes Filho, Gustavo A. Monti, Virginia Aiassa, Norma R. Sperandeo, Physicochemical characterization of deflazacourt: Thermal analysis, crystallographic and spectroscopic study, Steroids, (2007), 72, 261-269
    • 108. Eric Da Silva, Serge Bresson, Derick Rousseau, Characterization of the three major polymorphic forms and liquid state of tristearin by Raman spectroscopy, Chemistry and Physics of Lipids, (2009), 157, 113-119
    • 109. Zoltan Nemet, Gyozo Csonka Kis, Gyorgy Pokol, Adam Demeter, Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study, Jouurnal of Pharmaceutical and Biomedical Analysis, (2009), 49, 338- 346
    • 112. Alejandro P. Ayala, H.W. Siesler, R. Boese, G.G. Hoffmann, G.I. Polla, D.R. Vega, Solid state characterization of olanzapine polymorphs using vibrational spectroscopy, International Journal of Pharmaceutics, (2006), 326, 69-79
    • 113. Alejandro P. Ayala, H.W. Siesler, S.M.S.V. Wardell, N. Boechat, V. Dabbene, S.L. Cuffini, Vibrational spectra and quantum mechanical calculations of antiretroviral drugs: Nevirapine, Journal of Molecular Structure, (2007), 828, 201-210
    • 114. Alejandro P. Ayala, H.W. Siesler and S.L. Cuffini, Polymorphism incidence in commercial tablets of mebendazole: a vibrational spectroscopy investigation, Journal of Raman Spectroscopy, (2008), 39, 1150-1157
    • 115. Tandon P., G. Forster, R. Neubert, and S. Wartewig, Phase transitions in oleic acid as studied by X-ray diffraction and FT-Raman spectroscopy, Journal of Molecular Structure, (2000), 524, 201-215
    • 116. Vankeirsbilck T., A. Vercauteren, G. Van der Weken, F. Verpoort, G. Vergote, J.P. Remon, Applications of Raman spectroscopy in pharmaceutical analysis, Trends in Analytical Chemistry, 21, (2002) ,No. 12, 869-877
    • 117. Gandhi R. B., J.B. Bogardus, D.E. Bugay, R.K. Perrone, M.A. Kaplan, Pharmaceutical relationships of three solid state forms of stavudine, International Journal of Pharmaceutics, (2000), 201, 221-237
    • 118. Alejandro Pedro Ayala, Polymorphism in drugs investigated by low wave number Raman Scattering, Vibrational Spectroscopy, (2007), 45, 112-116
    • 119. Paul W. Findlay, David E. Bugay, Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms I, Journal of Pharmaceutical and Biomedical Analysis, (1998), 16, 921-930
    • 120. David E. Bugay, Characterization of the solid-state: spectroscopic techniques, Advanced Drug Delivery Reviews, (2001), 48, 43-65
    • 121. McCrone W. C., Fusion methods in chemical microscopy, Interscience Publishers, Inc., New York, 1957
    • 122. Mura P., M.T. Faucci, A. Manderioli, G. Bramanti, L. Ceccarelli, Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy, Journal of Pharmaceutical and Biomedical Analysis, (1998), 18, 151-163
    • 123. Scott M. Reed, T. J. R. Weakley, J. E. Hutchison, Polymorphism in a conformationally flexible substituted anthraquinone; a crystallographic, thermodynamic and molecular modelling studies, Crystal Engineering, (2000), 3(2), 85-99
    • 125. Martin C. J., and D. A. O'Connor, An experimental test of Lindemann's melting law, J. Phys. C: Solid State Phys., 10, (1977), 3521-3526
    • 126. Frank D. Stacey, Spiro S. Spiliopoulos and Mark A. Barton, A critical re-examination of the thermodynamic basis of the Lindemann's melting law, Physics of the Earth and Planetary Interiors, 55, (1989), 201-207
    • 128. Wolf G. H., R. Jeanloz, Lindemann melting law: anharmornic correction and test of its validity for minerals, J. Geophys. Res., 89, (1984), 7821-7835
    • 129. Gilvary J. J., The Lindemann and Grüneisen laws, Phys. Rev., 102, (1956), 308-316
    • 131. Ross M., Generalised Lindemann melting law, Phys. Rev., 184, (1969), 233-242
    • 132. Shapiro J. N., Lindemann law and lattice dynamics, Phys. Rev., B1, (1970), 3982-3989
    • 133. Stacey F. D. and Irvine R. D., Theory of melting: thermodynamic basis of Lindemann's law, Aust. J. Phys., 30, (1977a), 631-640
    • 144. Grooff D., M.M. De Villiers, W. Liebenberg, (2007). Thermal Methods for Evaluating Polymorphic transitions in Nifedipine, Thermochimica Acta, 454, 33-42
    • 145. Chan K. L. A., O.S. Fleming, S.G. Kazarian, D. Vassou, G.D. Chryssikos and V. Gionis, (2004). Polymorphism and Devitrification of Nifedipine under Controlled Humidity: a combined FT-Raman, IR and Raman microscopic investigation, Journal of Raman Spectroscopy, 35, 353-359
    • 146. Chan K. L. A., S.G. Kazarian, D. Vassou, G.D. Chryssikos and V. Gionis, (2007). In situ High-throughput Study of Drug Polymorphism under Controlled Temperature and Humidity using FT-IR Spectroscopic Imaging, Vibrational Spectroscopy, 43, 221-226
    • 147. Mino R. Caira, Yolande Robbertse, Jacobus J. Bergh, Mingna Song, Melgardt M. De Villiers, (2003). Structural Characterisation, Physicochemical Properties, and Thermal Stability of Three Crystal Forms of Nifedipine, Journal of Pharmaceutical Science, Vol. 92, No. 12, 2519-2533
    • 148. Triggle A. M., E. Shefter and D.J. Triggle, (1980). Crystal Structures of Calcium Channel Antagonists: 2,6-Dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine, J. Med. Chem., 23, 1442-1445
    • 149. Jervis H., S.G. Kazarian, K.L.A. Chan, D. Bruce, N. King (2004). Water vapour-induced mesoporous structure collapse observed by VGI and FT-IR spectroscopy, Vibrational Spectroscopy, Vol. 35, Issues 1-2, 225-231
    • 150. Xia Yang, Xiujuan Wang and Chi Bun Ching (2009). In situ monitoring of solid-state transition of p-aminobenzoic acid polymorphs using Raman spectroscopy, J. Raman Spectrosc., 40, 870-875
    • 151. Frausto-Reyes C., C. Medina-Gutierrez, R. Sato-Berru, L. R. Sahagun (2004). Qualitative study of ethanol content in Tequilas by Raman spectroscopy and principal component analysis, Spectrochemica Acta Part A 61 2657-2662
    • 152. Sato-Berru R. Y., E. V. Mejia-Uriarte, C. Frausto-Reyes, M. Villagran-Muniz, H. Murrieta S, J. M. Saniger (2006). Application of principal component analysis and Raman spectroscopy in the analysis of polycrystalline BaTiO3 at high pressure, Spectrochemica Acta Part A 66, 557-560
    • 153. Norman Chieng, Sonke Rehder, Dorothy Saville, Thomas Rade, Jaakko Aaltonen (2009). Quantitative solid-state analysis of three forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction, Journal of Pharmaceutical and Biomedical Analysis, 49, 18-25
    • 156. Burger A., Ramberger R., On the polymorphism of pharmaceuticals and other molecular crystals. II. Applicability of thermodynamic rules, Mikrochim. Acta (1979), 273-316
    • 157. Al-Saieq S. S., Riley G. S., Polymorphism in sulphonylurea hypoglycaemic agents: I. Tolbutamide, Pharm. Acta Helv., (1981), 56, 125-129
    • 158. Leary J. R., Ross S. D., Thomas M. J. K., On characterization of the polymorphs of tolbutamide, Pharm. Weekblad. Sci. Ed., (1981), 3, 62-66
    • 159. Umeda T., Ohnishi N., Yokoyama T., Kuroda T., Kita Y., Kuroda K., Tatsumi E., Matsuda Y., A kinetic study on the isothermal transition of polymorphic forms of tolbutamide and mefenamic acid in the solid state at high temperatures, Chem. Pharm. Bull, (1985), 33, 2073-2078
    • 160. Traue J., Kala, H. Kohler, M. Wenzel, U. Wiegeleben, A. Forster, B.;Pollandt, P. Pintye-Ho ´di, K. Szabo´-Revesz, P. Selmeczi, B., Untersuchungen zur polymorphie von arzneistoffen in pulvern und tabletten, Pharmazie, (1987), 42, 240-241
    • 172. Post M. L., O. Kennard and A. S. Horn, The tricyclic antidepressants: imipramine hydrochloride. The crystal and molecular structure of 5-(3-dimethylaminopropyl)-10,1ldihydro-5H-dibenz[b,f]azepine hydrochloride, Acta Cryst., B31, (1975), 1008-1013
    • 173. Heimstad E., Ø. Edvardsen and S. G. Dahl, Molecular structure and dynamics of trycyclic antidepressant drugs, European Neurpsychopharmacology, 1, (1991), 127-137
    • 174. Matousek, P., Parker, A.W., Bulk Raman Analysis of Pharmaceutical Tablets, Applied Spectroscopy, (2006), 60, Issue 12, 1353-1357
    • 175. Adrian C. Williams, V. Brett Cooper, Lisa Thomas, Letecia J. Griffith , Catherine R. Petts and Steven W. Booth, Evaluation of drug physical form during granulation, tabletting and storage, International Journal of Pharmaceutics, (2004), 275, 29-39
    • 176. Chao Wang, Thomas J. Vickers and Charles K. Mann, Direct assay and shelf-life monitoring of aspirin tablets using Raman spectroscopy, Journal of Pharmaceutical and Biomedical Analysis, (1997), 16, 87-94
    • 1. Poster titled, 'Polymorphism in Flufenamic Acid', presented at the Control and Prediction of the Organic Solid State (CPOSS) conference tagged: 'State of the Art and Challenges', held at the old refectory, University College London, on the 31st March 2009.
    • 2. Poster titled, 'Polymorphic fingerprinting using phonon-mode Raman spectroscopy', presented at the 1st RCUK China Summer School, Tagged Biomaterials for ageing population, held at Sichuan University, Chengdu, China, 19th-26th July, 2010.
    • 1. Best research proposal/ idea (as part of a team), at the 1st RCUK China Summer School, Tagged Biomaterials for ageing population, held at Sichuan University, Chengdu, China, 19th-26th July, 2010.
    • 1. Sarah Al-Dulami, Adeyinka Aina and Jonathan Burley, Rapid polymorph screening on milligram quantities of pharmaceutical material using phonon-mode Raman spectroscopy, CrystEngComm, 2010, 12, 1038-1040.
    • 2. Adeyinka Aina, Michael D. Hargreaves, Pavel Matousek and Jonathan C. Burley, Transmission Raman spectroscopy as a tool for quantifying polymorphic content of pharmaceutical formulations, Analyst, (2010),DOI: 10.1039/c0an00352b.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article